Sort
40,608 grants matching “prostate cancer”
Basic Research Support for the CCR
$955,878Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Michigan-VUMC Biomarker Characterization Center
$955,526Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U2C · FY2025 · CA
Mechanisms governing metastatic dormancy and reactivation
$955,499Filippo G Giancotti · Columbia University Health Sciences · R35 · FY2022 · CA
Comparative Effectiveness of Modern Therapies for Localized Prostate Cancer
$954,957David F Penson · Vanderbilt University Medical Center · R01 · FY2013 · HS
W81XWH2110098/ADDRESSING HEALTH LITERACY WITH A TAILORED SURVIVORSHIP CARE PLAN TO IMPROVE ACCESS IN UNDERSERVED AFRICAN AMERICAN PROSTATE CANCER PATIENTS.
$954,949Dana-Farber Cancer Institute, Inc. · · FY2021 · Defense Health Agency
NEW AWARD - REDUCING PROSTATE CANCER AGGRESSIVENESS VIA APTAMER-MEDIATED NUCLEAR DELIVERY OF SPLICE-SWITCHING OLIGONUCLEOTIDES....SIGNED 30-APR-2020, EFFECTIVE 15 MAY 2020, DISTRIBUTED 5/1/2020 FAADC 5/6/2020
$954,554The Johns Hopkins University · · FY2020 · Defense Health Agency
Enhancing Primary Care Capacity for Cancer Survivorship Care Delivery in Community Health Clinics
$954,481Bijal A. Balasubramanian · University Of Texas Hlth Sci Ctr Houston · U01 · FY2025 · CA
Intratumor heterogeneity and tumor evolution
$954,237Karl Ried · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Tissue Processing-Sequencing Facility
$954,130Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Transgenic Models for Prostate and Breast Cancer
$954,020Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Biospecimen procurement and tissue microarray manufacture for the CHTN
$953,928Christopher A. Moskaluk · University Of Virginia · UM1 · FY2021 · CA
Image Guided Therapy
$953,612Ferenc A Jolesz · Brigham And Women'S Hospital · P01 · FY2011 · CA
Southern Community Cohort Study
$952,483William J. Blot · Vanderbilt University Medical Center · R01 · FY2015 · CA
Mechanisms of resistance to treatment in aggressive prostate cancers
$952,361Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Molecular alterations driving the development of primary prostate cancers
$952,361Adam Sowalsky · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor
$952,237Hua Zhao · University Of Virginia · U01 · FY2025 · CA
Role of Neurotrophins in the Development of the Mammalian Nervous System
$952,123Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
GENERAL CLINICAL RESEARCH CENTER
$951,937Medical University Of South Carolina · M01 · FY2000 · RR
CENTER FOR BIOMEDICAL RESEARCH
$951,368Clayton Yates · Tuskegee University · G12 · FY2016 · MD
INVESTIGATING A NOVEL APPROACH FOR TARGETING WNT-DRIVEN PROSTATE CANCERS
$951,000Regents Of The University Of California, San Francisco, The · · FY2018 · Department of the Army
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$950,923Mary Christine Playdon · University Of Utah · U01 · FY2023 · CA
Genome-wide scan for genetic variants associated with early-onset prostate cancer
$950,901Kathleen A Cooney · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
$950,808Harold H Koeffler · University Of California Los Angeles · U54 · FY2010 · CA
Leveraging Diversity in Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk Scores
$950,000David V Conti · University Of Southern California · U01 · FY2024 · CA
Developmental Reprogramming of Prostate Carcinogenesis by BPA
$950,000Cheryl L Walker · University Of Tx Md Anderson Can Ctr · RC2 · FY2009 · ES